Sarah Hymowitz is a Partner at The Column Group where she invests in Series A-stage startups in biotechnology, drug discovery, structural biology, and protein sciences. She’s operating out of an over $400M fund raised in February 2024. She has invested in companies like InduPro, Surrozen, Synthekine, RAPT Therapeutics, and ORIC Pharmaceuticals. Before The Column Group, she held senior roles at Genentech, including Vice President, Protein Sciences, and Vice President, Protein Chemistry & Structural Biology. Sarah studied at the University of California, San Francisco, and lives in San Francisco, California.
Sarah Hymowitz, Partner @ The Column. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Sarah Hymowitz from The Column Group. Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Sarah
Map your path to Sarah instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Sarah
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.